PA Consulting identifies the top three questions that biopharmaceutical companies should consider before launching a direct-to-patient platform and service offering.
- Companies To Watch: OSE Immunotherapeutics
- A Deeper Look At What's Driving Dependence On Biotech Contract Manufacturers
- Navigating Growth In Biotech: A First-Person Insight
- Michigan No Longer A Safe Haven For Pharmaceutical Companies?
- Continuing Down The Road To BioPharma Board Diversification
- Delivering The Next Evolution In Immuno-Oncology
- Start Fast, Finish Fast: How To Complete Projects On Time
- Small Startup Going For A Big Play In Obesity
COMPANIES TO WATCH
-
Companies To Watch: OSE Immunotherapeutics
OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.
-
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
-
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
-
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
WHERE ARE THEY NOW
-
Where Are They Now? SQZ Biotech
SQZ Biotech, a novel cell therapy company with Big Pharma backing, is no more. However, the company's science, and its founding CEO, will continue on under new auspices.
-
Where Are They Now? Novo Nordisk
In a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
-
Where Are They Now? Ono Pharmaceuticals
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
NEWSLETTER ARCHIVE
- 05.03.24 -- Reviva Pharma's Novel Funding Approach
- 05.03.24 -- Listen now: Precision Drug Delivery, Clinical Trial Progress for Parkinson's, Funding Alzheimer's Tx, and more.
- 05.01.24 -- What's Behind Biotech Contract Manufacturing Growth
- 04.30.24 -- Ocular Drug Delivery Systems: The Advantages Of Nanoparticles
- 04.29.24 -- Companies To Watch: OSE Immunotherapeutics